NS32365/NS/NINDS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1995	1
1997	2
1998	6
1999	3
2000	1
2022	0

1

Aging, energy, and oxidative stress in neurodegenerative diseases.

Beal MF. Beal MF. Ann Neurol. 1995 Sep;38(3):357-66. doi: 10.1002/ana.410380304. Ann Neurol. 1995. PMID: 7668820 Review.

2

A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.

Shults CW, Haas RH, Beal MF. Shults CW, et al. Biofactors. 1999;9(2-4):267-72. doi: 10.1002/biof.5520090223. Biofactors. 1999. PMID: 10416040 Review.

3

Creatine and cyclocreatine attenuate MPTP neurotoxicity.

Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF. Matthews RT, et al. Exp Neurol. 1999 May;157(1):142-9. doi: 10.1006/exnr.1999.7049. Exp Neurol. 1999. PMID: 10222117

4

Manganese superoxide dismutase overexpression attenuates MPTP toxicity.

Klivenyi P, St Clair D, Wermer M, Yen HC, Oberley T, Yang L, Flint Beal M. Klivenyi P, et al. Neurobiol Dis. 1998 Oct;5(4):253-8. doi: 10.1006/nbdi.1998.0191. Neurobiol Dis. 1998. PMID: 9848095

5

Neuroprotective effects of creatine administration against NMDA and malonate toxicity.

Malcon C, Kaddurah-Daouk R, Beal MF. Malcon C, et al. Brain Res. 2000 Mar 31;860(1-2):195-8. doi: 10.1016/s0006-8993(00)02038-2. Brain Res. 2000. PMID: 10727643

6

Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.

Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Koroshetz WJ, et al. Ann Neurol. 1997 Feb;41(2):160-5. doi: 10.1002/ana.410410206. Ann Neurol. 1997. PMID: 9029064

7

Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.

Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, Beal MF. Matthews RT, et al. J Neurosci. 1998 Jan 1;18(1):156-63. doi: 10.1523/JNEUROSCI.18-01-00156.1998. J Neurosci. 1998. PMID: 9412496 Free PMC article.

8

Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease.

Bogdanov MB, Ferrante RJ, Kuemmerle S, Klivenyi P, Beal MF. Bogdanov MB, et al. J Neurochem. 1998 Dec;71(6):2642-4. doi: 10.1046/j.1471-4159.1998.71062642.x. J Neurochem. 1998. PMID: 9832167 Free article.

9

Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats.

Ayoub IA, Lee EJ, Ogilvy CS, Beal MF, Maynard KI. Ayoub IA, et al. Neurosci Lett. 1999 Jan 4;259(1):21-4. doi: 10.1016/s0304-3940(98)00881-7. Neurosci Lett. 1999. PMID: 10027546

10

Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.

Shults CW, Haas RH, Passov D, Beal MF. Shults CW, et al. Ann Neurol. 1997 Aug;42(2):261-4. doi: 10.1002/ana.410420221. Ann Neurol. 1997. PMID: 9266740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results